Galderma Group AG (GALDY)

OTCMKTS · Delayed Price · Currency is USD
31.60
-2.34 (-6.90%)
Jul 28, 2025, 9:30 AM EDT
-6.90%
Market Cap37.79B
Revenue (ttm)4.69B
Net Income (ttm)378.00M
Shares Outn/a
EPS (ttm)1.59
PE Ratio99.97
Forward PE46.85
Dividend0.02 (0.07%)
Ex-Dividend DateApr 28, 2025
Volume10,186
Average Volume16,250
Open33.27
Previous Close33.94
Day's Range31.59 - 33.32
52-Week Range16.20 - 34.02
Betan/a
RSI54.90
Earnings DateJul 24, 2025

About Galderma Group AG

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Actinica, Dysport/Azzalure, Alluzience, Restylane and Restylane Skinboosters, Sculptra, Cetaphil and Alastin, Soolantra, Epiduo and Epiduo Forte, Differin, Aklief, Epsolay, Twyneo, Oracea, Metvix, Mirvaso, Nemluvio, Relfydess, Benzac, Loceryl, and TRI-LUMA in ... [Read more]

Industry Pharmaceutical Preparations
Founded 1981
Employees 6,545
Stock Exchange OTCMKTS
Ticker Symbol GALDY
Full Company Profile

Financial Performance

Financial Statements

News

Galderma Announces Departure of Its Chief Financial Officer

ZUG, Switzerland--(BUSINESS WIRE)--Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that Thomas Dittrich, Chief Financial Officer, will be leaving the company t...

4 weeks ago - Business Wire

Galderma Initiates Two New Clinical Trials Investigating Nemolizumab in Patients With Systemic Sclerosis and Chronic Pruritus of Unknown Origin

ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the initiation of two new clinical trials to investigate the efficacy and safety of ...

4 weeks ago - Business Wire

Galderma establishes new U.S. headquarters in Miami and strengthens regional leadership

Strategic move aims to accelerate innovation and growth in the U.S., Galderma's largest region MIAMI , June 17, 2025 /PRNewswire/ -- Galderma (SIX: GALD), the pure-play dermatology category leader, to...

6 weeks ago - PRNewsWire